Status: current, Defined. Date: 31-Jul 2020. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4432861000168112 | Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted antigen 50 microgram) powder for injection, 50 microgram vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 4432871000168118 | Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted antigen 50 microgram) powder for injection, 50 microgram vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 4433001000168113 | Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | Is a | Shingrix | true | Inferred relationship | Some | ||
| Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | Is a | varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine injection, vial | true | Inferred relationship | Some | ||
| Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | has manufactured dose form | powder for injection | true | Inferred relationship | Some | ||
| Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | has Australian BoSS | varicella-zoster virus glycoprotein E recombinant adjuvanted antigen | true | Inferred relationship | Some | 2045182839 | |
| Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | has intended active ingredient | varicella-zoster virus glycoprotein E recombinant adjuvanted antigen | true | Inferred relationship | Some | 2045182839 | |
| Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | has unit of use | vial | true | Inferred relationship | Some | 1341371944 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Shingrix (1 x vaccine vial, 1 x 0.5 mL inert diluent vial), 1 pack | has TPUU | True | Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | Inferred relationship | Some | 1327784270 |
| Shingrix (10 x vaccine vials, 10 x 0.5 mL inert diluent vials), 1 pack | has TPUU | True | Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | Inferred relationship | Some | 1516047099 |
| Shingrix (1 x vaccine vial, 1 x 0.5 mL inert diluent vial), 1 pack | has TPUU | True | Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | Inferred relationship | Some | 31217681 |
| Shingrix (10 x vaccine vials, 10 x 0.5 mL inert diluent vials), 1 pack | has TPUU | True | Shingrix (varicella-zoster virus glycoprotein E recombinant adjuvanted vaccine) powder for injection, vial | Inferred relationship | Some | 1240061602 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR